EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program

Karoline Andersen iD, Jesper Bonde iD, Marianne Waldstrøm, Maria Vad Jakobsen, Philippe Lamy, Helle Pedersen, Sara Bønløkke iD, Magnus Stougaard, Torben Steiniche

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Karoline Andersen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Aarhus University, Denmark. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomaviridae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sygeforsikringen "danmark", Fabrikant Einar Willumsens Mindelegat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The carcinogenicity of HPV genotypes is well established. However, HPV genotypes have sublineages with individual risk profiles, and these are much less described with respect to carcinogenicity. Research to characterize HPV sublineages by next‐generation sequencing (NGS) on screening‐derived liquid‐based cytology (LBC) samples is limited because of the technical and quality assurance challenging nature of sublineage analysis. This study aimed to evaluate the feasibility of detecting HPV sublineages from 14 HPV genotypes in SurePath LBC samples from Danish cervical cancer screening. We included 41 HPV plasmids (the Global HPV LabNet DNA Genotyping Proficiency Panel 2023) to quality assure the NGS approach and 120 SurePath LBC samples from the screening program for proof of concept. Our results of the HPV plasmids showed the correct sublineage for all included HPV genotypes except for HPV68b, where the coverage was inadequate for sublineage analysis. The NGS analysis enabled HPV sublineage analysis in 99.1% (112/113) of HPV‐positive SurePath LBC samples. Sublineages belonging to the A lineage were most frequent for HPV16, 18, 31, 33, 35, 39, 51, 52, 58, 59, and 68, while B‐type sublineages showed the highest frequency in HPV45, 56, and 66. The most diverse sublineage data was obtained for HPV31 with sublineages from the A, B, and C lineages. In conclusion, our method enables the identification of HPV sublineages in SurePath LBC screening samples. This information can be used in future studies to determine the usefulness of HPV sublineage analysis in screening settings for risk stratification and clinical management of HPV‐positive women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingPapillomavirus InfectionsUterine Cervical NeoplasmsPapillomaviridaeHumansFemaleDenmarkGenotypeEarly Detection of CancerMiddle AgedAdultDNA, ViralCervix UteriVaginal SmearsCytodiagnosisAlphapapillomavirus

Stichwörter der Autor:innen

HPVHPV sublineagesNGScervical cancer screeningliquid‐based cytology

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Clinical Medicine, Aarhus University, Denmark.
  • Department of Pathology, Aarhus University Hospital, Denmark.
  • Molecular Pathology laboratory, Department of Pathology, AHH-Hvidovre Hospital, Denmark.
  • Department of Molecular Medicine, Aarhus University Hospital, Denmark.
  • Department of Obstetrics and Gynecology, Gødstrup Regional Hospital, Denmark.
  • Department of Clinical Genetics, Aarhus University Hospital, Denmark.

ORCID-Profile: Karoline Andersen, Jesper Bonde, Sara Bønløkke

Förderung

  • Sygeforsikringen "danmark"
  • Fabrikant Einar Willumsens Mindelegat

Zitieren

APA

Andersen, K., Bonde, J., Waldstrøm, M., Jakobsen, M. V., Lamy, P., Pedersen, H., Bønløkke, S., Stougaard, M., & Steiniche, T. (2026). Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program. International Journal of Cancer. https://doi.org/10.1002/ijc.70148

Vancouver

Andersen K, Bonde J, Waldstrøm M, Jakobsen MV, Lamy P, Pedersen H, et al. Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program. International Journal of Cancer. 2026. doi:10.1002/ijc.70148

BibTeX
@article{Andersen2026,
  author = {Andersen, Karoline and Bonde, Jesper and Waldstrøm, Marianne and Jakobsen, Maria Vad and Lamy, Philippe and Pedersen, Helle and Bønløkke, Sara and Stougaard, Magnus and Steiniche, Torben},
  title = {Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70148}
}
Kostenlos starten →